BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9216829)

  • 1. (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor.
    Fung AK; Baker WR; Fakhoury S; Stein HH; Cohen J; Donner BG; Garvey DS; Spina KP; Rosenberg SH
    J Med Chem; 1997 Jul; 40(14):2123-5. PubMed ID: 9216829
    [No Abstract]   [Full Text] [Related]  

  • 2. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
    Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
    Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
    Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
    Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
    Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
    J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.
    Ichikawa M; Yokomizo A; Itoh M; Haginoya N; Sugita K; Usui H; Terayama K; Kanda A
    Bioorg Med Chem; 2011 Sep; 19(17):5207-24. PubMed ID: 21802309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
    Nishimoto T; Amano Y; Tozawa R; Ishikawa E; Imura Y; Yukimasa H; Sugiyama Y
    Br J Pharmacol; 2003 Jul; 139(5):911-8. PubMed ID: 12839864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenoxypropylamines: a new series of squalene synthase inhibitors.
    Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
    J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
    [No Abstract]   [Full Text] [Related]  

  • 10. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
    Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
    J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N-(beta-D-glucopyranosyl) monoamides of dicarboxylic acids as potential inhibitors of glycogen phosphorylase.
    Czifrák K; Hadady Z; Docsa T; Gergely P; Schmidt J; Wessjohann L; Somsák L
    Carbohydr Res; 2006 Jun; 341(8):947-56. PubMed ID: 16564511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moiety.
    Dickson JK; Biller SA; Magnin DR; Petrillo EW; Hillyer JW; Hsieh DC; Lan SJ; Rinehart JK; Gregg RE; Harrity TW; Jolibois KG; Kalinowski SS; Kunselman LK; Mookhtiar KA; Ciosek CP
    J Med Chem; 1996 Feb; 39(3):661-4. PubMed ID: 8576906
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
    Miki T; Kori M; Mabuchi H; Tozawa R; Nishimoto T; Sugiyama Y; Teshima K; Yukimasa H
    J Med Chem; 2002 Sep; 45(20):4571-80. PubMed ID: 12238936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
    Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
    J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.
    Griebenow N; Flessner T; Buchmueller A; Raabe M; Bischoff H; Kolkhof P
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2554-8. PubMed ID: 21396815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.
    Griebenow N; Buchmueller A; Kolkhof P; Schamberger J; Bischoff H
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3648-53. PubMed ID: 21576018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
    Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.